The Role of Transbronchial Lung Biopsy in Diagnosing Pulmonary Mucormycosis in a Critical Care Unit
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Pulmonary mucormycosis (PM) is an emerging infectious disease and a life-threatening infection with high mortality. The clinical outcomes of PM have not improved significantly over the last decade because early diagnosis of PM is difficult and antifungal agents show limited activity. We evaluated the clinical manifestations of PM in a Korean tertiary hospital and identified the role of transbronchial lung biopsy (TBLB) in diagnosing PM in patients admitted to an intensive care unit. Methods: The medical records of adult patients (aged 16 years and older) who met the criteria for proven or probable PM in a Korean tertiary hospital were retrospectively reviewed from January 2003 to December 2013. The clinical features, computed tomographic findings, diagnostic methods, treatment, and outcomes in patients with PM were evaluated. Results: Of the nine patients, four were male. The median age was 64 years (range, 12 to 73 years). PM was proven and probable in seven and two cases, respectively. Computed tomography findings of PM were unilateral involvement in eight cases (89%), consolidation in eight (89%), ground glass opacity in four (44%), and reverse halo sign in one (11%). Six of nine cases (67%) were diagnosed as PM from TBLB via portable bronchoscopy. There were no complications after TBLB. Mortality rate was 56% (five of nine cases). Conclusions: TBLB can be an easy and useful technique for diagnosing PM in the intensive care unit.
Abstract
Background: Pulmonary mucormycosis (PM) is an emerging infectious disease and a life-threatening infection with high mortality. The clinical outcomes of PM have not improved significantly over the last decade because early diagnosis of PM is difficult and antifungal agents show limited activity. We evaluated the clinical manifestations of PM in a Korean tertiary hospital and identified the role of transbronchial lung biopsy (TBLB) in diagnosing PM in patients admitted to an intensive care unit. Methods: The medical records of adult patients (aged 16 years and older) who met the criteria for proven or probable PM in a Korean tertiary hospital were retrospectively reviewed from January 2003 to December 2013. The clinical features, computed tomographic findings, diagnostic methods, treatment, and outcomes in patients with PM were evaluated. Results: Of the nine patients, four were male. The median age was 64 years (range, 12 to 73 years). PM was proven and probable in seven and two cases, respectively. Computed tomography findings of PM were unilateral involvement in eight cases (89%), consolidation in eight (89%), ground glass opacity in four (44%), and reverse halo sign in one (11%). Six of nine cases (67%) were diagnosed as PM from TBLB via portable bronchoscopy. There were no complications after TBLB. Mortality rate was 56% (five of nine cases). Conclusions: TBLB can be an easy and useful technique for diagnosing PM in the intensive care unit.
참고문헌 (23)
- Garcia-Hermoso D, "Manual of clinical microbiology", pp.1880~1901 (2011), ASM Press
- Kontoyiannis DP, "Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases", J Infect Dis, 191 (2005)
- Ibrahim AS, "Pathogenesis of mucormycosis", Clin Infect Dis, 54(Suppl 1), pp.S16~S22 (2012)
- Riley TT, "Breaking the mold: a review of mucormycosis and current pharmacological treatment options", Ann Pharmacother, 50, pp.747~757 (2016)
- Pagano L, "Mucormycosis in hematologic patients", Haematologica, 89, pp.207~214 (2004)
- Roden MM, "Epidemiology and outcome of zygomycosis: a review of 929reported cases", Clin Infect Dis, 41, pp.634~653 (2005)
- Hamilos G, "Pulmonary mucormycosis", Semin Respir Crit Care Med, 32, pp.693~702 (2011)
- Rees JR, "The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance", Clin Infect Dis, 27, pp.1138~1147 (1998)
- Jung J, "Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis", Clin Microbiol Infect, 21, pp.684.e11~684.e18 (2015)
- al-Abbadi MA, "Pulmonary mucormycosis diagnosed by bronchoalveolar lavage:a case report and review of the literature", Pediatr Pulmonol, 23, pp.222~225 (1997)
- Sharma S, "Pulmonary infections in immunocompromised patients: the role of image-guided fine needle aspiration cytology", Cytopathology, 28, pp.46~54 (2017)
- De Pauw B, "Revised definitions of invasive fungal disease from the European organization for Research and Treatment of Cancer", Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC, Clin Infect Dis, pp.2008, 46[DOI]
- Kim YI, "Invasive pulmonary mucormycosis with concomitant lung cancer presented with massive hemoptysis by huge pseudoaneurysm of pulmonary artery.", Ann Thorac Surg, 98, pp.1832~1835 (2014)
- Neto FM, "Fungal infection by Mucorales order in lung transplantation: 4 case reports", Transplant Proc, 46, pp.1849~1851 (2014)
- McAdams HP, "Pulmonary mucormycosis: radiologic findings in 32 cases", AJR Am J Roentgenol, 168, pp.1541~1548 (1997)
- Jamadar DA, "Pulmonary zygomycosis: CT appearance", J Comput Assist Tomogr, 19, pp.733~738 (1995)
- Walsh TJ, "Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)", Clin Infect Dis, 54(Suppl 1), pp.S55~S60 (2012)
- Almyroudis NG, "In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents", Antimicrob Agents Chemother, 51, pp.2587~2590 (2007)
- Drogari-Apiranthitou M, "In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs", J Antimicrob Chemother, 67, pp.1937~1940 (2012)
- Lamaris GA, "Increased virulence of Zygomycetes organisms following exposure to voriconazole:a study involving fly and murine models of zygomycosis", J Infect Dis, 199, pp.1399~1406 (2009)
- Schneidawind D, "Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis", Transpl Infect Dis, 14, pp.E166~E172 (2012)
- Fitzpatrick MC, "Pulmonary mucormycosis complicating cutaneous blastic plasmacytoid dendritic cell neoplasm", Proc (Bayl Univ Med Cent), 25, pp.287~288 (2012)
- Serio B, "Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report", Infez Med, 20(Suppl 2), pp.43~47 (2012)